|
Name |
(1R,3S,7R,8E,11S,12R)-1,4-dimethyl-12-[(2R,3Z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.03,7]tetradeca-4,8-diene-8-carbaldehyde
|
Molecular Formula | C25H34O2 | |
IUPAC Name* |
(1R,3S,7R,8E,11S,12R)-1,4-dimethyl-12-[(2R,3Z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.03,7]tetradeca-4,8-diene-8-carbaldehyde
|
|
SMILES |
CC1=CC(=O)[C@@H]/2[C@@H]1C[C@]3(CC[C@@H]([C@@H]3C/C=C2/C=O)[C@H](C)/C=C\C=C(C)C)C
|
|
InChI |
InChI=1S/C25H34O2/c1-16(2)7-6-8-17(3)20-11-12-25(5)14-21-18(4)13-23(27)24(21)19(15-26)9-10-22(20)25/h6-9,13,15,17,20-22,24H,10-12,14H2,1-5H3/b8-6-,19-9-/t17-,20-,21-,22+,24+,25-/m1/s1
|
|
InChIKey |
RKNMPQSLAZUFIT-MNZSMBGHSA-N
|
|
Synonyms |
6-epi-Ophiobolin G
|
|
CAS | NA | |
PubChem CID | 102332996 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 366.5 | ALogp: | 5.8 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 34.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 27 | QED Weighted: | 0.454 |
Caco-2 Permeability: | -4.629 | MDCK Permeability: | 0.00001900 |
Pgp-inhibitor: | 0.982 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.032 | 20% Bioavailability (F20%): | 0.737 |
30% Bioavailability (F30%): | 0.022 |
Blood-Brain-Barrier Penetration (BBB): | 0.018 | Plasma Protein Binding (PPB): | 96.42% |
Volume Distribution (VD): | 2.533 | Fu: | 3.29% |
CYP1A2-inhibitor: | 0.946 | CYP1A2-substrate: | 0.67 |
CYP2C19-inhibitor: | 0.937 | CYP2C19-substrate: | 0.867 |
CYP2C9-inhibitor: | 0.923 | CYP2C9-substrate: | 0.038 |
CYP2D6-inhibitor: | 0.967 | CYP2D6-substrate: | 0.022 |
CYP3A4-inhibitor: | 0.958 | CYP3A4-substrate: | 0.811 |
Clearance (CL): | 4.86 | Half-life (T1/2): | 0.151 |
hERG Blockers: | 0.538 | Human Hepatotoxicity (H-HT): | 0.352 |
Drug-inuced Liver Injury (DILI): | 0.316 | AMES Toxicity: | 0.042 |
Rat Oral Acute Toxicity: | 0.244 | Maximum Recommended Daily Dose: | 0.912 |
Skin Sensitization: | 0.952 | Carcinogencity: | 0.815 |
Eye Corrosion: | 0.012 | Eye Irritation: | 0.127 |
Respiratory Toxicity: | 0.978 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005803 | 0.783 | D0V2JK | 0.265 | ||||
ENC002981 | 0.708 | D06AEO | 0.250 | ||||
ENC003783 | 0.685 | D04GJN | 0.246 | ||||
ENC002000 | 0.685 | D0P0HT | 0.237 | ||||
ENC003777 | 0.685 | D04SFH | 0.235 | ||||
ENC002982 | 0.606 | D0F1UL | 0.232 | ||||
ENC002983 | 0.515 | D0D2TN | 0.225 | ||||
ENC005044 | 0.500 | D0I2SD | 0.224 | ||||
ENC005045 | 0.485 | D04ATM | 0.222 | ||||
ENC003687 | 0.467 | D07BSQ | 0.221 |